Tumour-induced osteomalacia due to thymolipoma
- PMID: 34825545
- DOI: 10.25259/NMJI_272_20
Tumour-induced osteomalacia due to thymolipoma
References
-
- Pal R, Bhadada SK, Shingare A, Bhansali A, Kamalanathan S, Chadha M, et al. Tumour-induced osteomalacia: Experience from three tertiary care centres in India. Endocr Connect. 2019; pii - EC-18-0552R1
-
- Shah R, Lila AR, Jadhav S, Patil VA, Mahajan A, Sonawane S, et al. Tumour induced osteomalacia in head and neck region: Single center experience and systematic review. Endocr Connect. 2019; pii - EC-19-0341
-
- Zuo QY, Wang H, Li W, Niu XH, Huang YH, Chen J, et al. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: Retrospective review of 12 patients. BMC Musculoskelet Disord. 2017; 18:403
-
- Kaniuka-Jakubowska S, Biernat W, Lewczuk A, Świ þ atkowska-Stodulska R, Sworczak K,. Oncogenic osteomalacia should be considered in hypophosphatemia, bone pain and pathological fractures. Endokrynol Pol. 2012; 63:234-8
-
- den Bakker MA, Marx A, Mukai K, Ströbel P,. Mesenchymal tumours of the mediastinum. Part I. Virchows Arch. 2015; 467:487-500